Work

A Phase II Study of Ruxolitinib Pre-, during- and Post-Hematopoietic Celltransplantation for Patients with Primary or Secondary Myelofibrosis

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-146330

Authors: Gabriela Hobbs, Haesook T. Kim, AJ S. Bottoms, Michael T. Byrne, Mark A. Schroeder, Roni Tamari, Sarah A Wall, Zachariah Defilipp, Areej El-Jawahri, Steven McAfee, Yi-Bin Chen

Institutions: Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Vanderbilt University Medical Center, Washington University in St. Louis, Memorial Sloan Kettering Cancer Center, The Ohio State University

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3214080626

Cites:

Cited by: 7

Related to: 10